DelawareDE-Licensed Physicians

GLP-1 Weight Loss Telehealth in Delaware

Doctor-prescribed semaglutide and tirzepatide for Delaware residents, opening soon. DE-licensed physicians, transparent pricing, and discreet shipping, for residents of Wilmington, Dover, Newark, Middletown,Smyrna, and every other Delaware community.

Plans from$179first month
Start Your Assessment

Free · 2-minute assessment · Founding-member access

Can you get GLP-1 weight loss medication in Delaware?

Yes. Delaware residents can get doctor-prescribed GLP-1 medication through telehealth without an in-person visit. Through Majesta Health, once we open, an DE-licensed physician reviews your medical assessment online, and if you qualify, compounded semaglutide or tirzepatide is prescribed and shipped discreetly to your Delaware address from a state-licensed pharmacy. Plans start at $179 your first month. The process is designed so that review and shipping fit within about 5 to 7 business days once we open. Compounded medications are not FDA-approved as final products, and results may vary.

Updated .

What Is Included

What Delaware members get with Majesta Health at launch

Everything included in one monthly price, no hidden fees, no surprise renewals, no subscription games.

DE-licensed physicians

Every prescription will be reviewed and signed by a physician licensed by the Delaware Board of Medical Licensure and Discipline. Our model pairs you with one doctor throughout treatment, not a different one every refill.

Privacy under HIPAA

Your medical history and conversations stay private. We handle your health information under HIPAA-compliant practices in first-party systems, and your data is encrypted in transit (TLS).

Discreet home delivery

Plain, signature-required packaging, reaching every Delaware address, including Wilmington, once we open.

Transparent pricing

Two plans from $179 your first month. Doctor visits, medication, and ongoing support are all included on every plan. No upcharges.

Message-based physician access

Side effect questions? Dose adjustment needs? Our model is message-based care with your team, not call centers.

Why It Matters

Why GLP-1 telehealth matters in Delaware

Delaware is home to roughly 1.0 million people, and about 33.9% of Delawareadults have obesity. Whether treatment is appropriate for any individual is a licensed physician's decision; access should not depend on long waits or expensive in-person visits.

Cities like Wilmington, Dover, Newark have great healthcare networks, but obesity-medicine specialists often have months-long waitlists. Telehealth bridges that gap. From your home anywhere in Delaware, you can complete a medical assessment and be reviewed by a DE-licensed physician, without an office visit, once we open.

Delaware telehealth rules: Delaware allows licensed physicians to prescribe non-controlled medications via telehealth, including compounded GLP-1 medications dispensed by state-licensed pharmacies.

Delaware gathered its telehealth rules into one place: Chapter 60 of Title 24 of the Delaware Code, titled Provisions Applicable to Telehealth and Telemedicine. It applies across twelve licensing boards at once, including the Board of Medical Licensure and Discipline that governs physicians (section 6002(a)(3)). So the rules below are not a medical-board policy that could quietly change; they are statute, passed by the General Assembly. Start with who may treat you. Section 6002(c) is unusually explicit about out-of-state providers: a health-care provider licensed in a state that has not adopted an applicable interstate compact "may only provide telehealth under this chapter if the health-care provider obtains an interstate telehealth registration from the Division of Professional Regulation." Eligibility for that registration has four conditions that must be "continuously met": a valid, active license in another state, good standing in every state of licensure, no pending administrative complaint, and no current investigation anywhere, including Delaware. And section 6002(d) closes the loop most states leave open: a registered out-of-state provider "consents and agrees" to be subject to Delaware law, the personal jurisdiction of Delaware courts, and the Delaware board's complaint, investigation, and hearing process. If something goes wrong, you do not have to chase a doctor into another state's system. Next, how the relationship begins. Section 6003(a) says a provider-patient relationship "may be established either in-person or through telehealth and telemedicine," so a first visit by video is lawful, but the statute then lists seven things the encounter must include: verification of your location and identity, disclosure of the provider's identity and credentials, informed consent about the telemedicine technology being used, a diagnosis established "through the use of acceptable medical practices" such as history, examination, and appropriate testing, a discussion of the diagnosis and the risks and benefits of the treatment options, arranged follow-up coverage, and "a written visit summary provided to the patient." Section 6003(b) adds the governing test: telehealth may be used to establish the relationship only if the provider determines they can meet "the same standard of care as if the health-care services were being provided in-person." On the format of the visit, Delaware is more permissive than many states, with one deliberate catch. Section 6003(b) allows services to be "synchronous or asynchronous using store-and-forward technology." The definition of telemedicine in section 6001(6) covers real-time two-way audio and visual communication, and it permits audio-only conversations, but only "if the patient is not able to access the appropriate broadband service or other technology necessary to establish an audio and visual connection." In other words, a phone call is a fallback the law reserves for patients who genuinely cannot get on video, not the default way to be seen. Finally, prescribing. Section 6003(c) holds telehealth to "the same standards of appropriate practice as those in traditional (in-person encounter) settings," and then draws the line that matters for GLP-1 care: absent a proper provider-patient relationship, providers "are prohibited from issuing prescriptions solely in response to an internet questionnaire, an internet consult, or a telephone consult." An intake form can start the process in Delaware; it can never be the whole process. A licensed or Delaware-registered clinician must actually establish the relationship, make a diagnosis by acceptable medical practice, and document the visit before any prescription is appropriate. That is the model Delaware wrote into law, and it is the model any telehealth service treating Delaware patients has to follow.

Verified Delaware facts, checked September 15, 2026

Each item below was read on the state's own page by two independent readers on that date. Items we could not verify are not listed.

You can verify any physician's Delaware license at the Delaware Board of Medical Licensure and Discipline.

How It Works

How it works in Delaware

  1. 1

    Start your 2-minute assessment

    A short health questionnaire about your medical history, current medications, and weight loss goals. We screen for the contraindications that matter, including thyroid history, pancreatitis, and gallbladder issues. There is no charge to start the assessment. If you enroll, nothing is charged at checkout: your first month's price is charged only after the physician reviews your file and approves treatment, and it includes a $20 medical consultation fee paid through to the licensed physician. If the physician does not approve treatment, you are not charged.

  2. 2

    A real DE-licensed doctor reviews your file

    Not an AI, not a form bot. Once we open, a physician licensed in Delaware reads your full assessment and decides whether GLP-1 is right for you. Where Delaware telehealth rules require it, or where the physician decides it is needed, your evaluation includes a phone or video visit before any prescription. If it's not right for you, they'll tell you that, too, honestly.

  3. 3

    Your medication ships discreetly to your Delaware address

    Compounded medication is dispensed by a state-licensed pharmacy in plain packaging, covering every Delaware address, from Wilmington and Dover to rural ZIP codes, once we open.

  4. 4

    Message your doctor anytime

    Side effect questions, dose adjustments, food and lifestyle questions, they're all included. The program is designed so you always have the same doctor.

FAQ

Frequently asked questions about GLP-1 in Delaware

Can a doctor licensed in another state treat me in Delaware by telehealth?

The statute frames it as two doors. 24 Del. C. section 6002(c) addresses a health-care provider licensed in a state that has not adopted an interstate compact applicable to that provider: such a provider may provide telehealth only after obtaining an interstate telehealth registration from Delaware's Division of Professional Regulation. So a provider is either covered by an applicable interstate compact or must hold the Delaware registration. The registration requires a valid, active license issued by another state, good standing in every state of licensure, no administrative complaint pending before another state's licensing authority or board, and no current investigation by another state's authority or any authority in Delaware, and those conditions must be continuously met. Under section 6002(d), a registered provider also consents to Delaware law, the personal jurisdiction of Delaware courts, and the Delaware licensing board's complaint, investigation, and hearing process.

Is an audio-only phone visit allowed in Delaware?

As an exception, not a default. Section 6001(6) defines telemedicine to include real-time two-way audio and visual communication, and it permits audio-only conversations only if the patient is not able to access the appropriate broadband service or other technology necessary to establish an audio and visual connection. If you can get on video, Delaware expects the visit to happen on video.

Can I get a prescription in Delaware just by filling out an online questionnaire?

No. Section 6003(c) states that in the absence of a proper health-care provider-patient relationship, providers are prohibited from issuing prescriptions solely in response to an internet questionnaire, an internet consult, or a telephone consult. The relationship itself may be established by telehealth under section 6003(a), but it must include verification of your identity and location, informed consent, a diagnosis established through acceptable medical practices, discussion of treatment options, follow-up coverage, and a written visit summary.

Can I get GLP-1 medication through telehealth in Delaware?

Yes. Delaware residents can be prescribed GLP-1 medications through telehealth where a licensed physician finds treatment appropriate. Through Majesta Health, once we open enrollment, a Delaware-licensed physician reviews your assessment, and medication is dispensed by a state-licensed compounding pharmacy and shipped discreetly to your home.

How much does GLP-1 cost in Delaware?

Through Majesta Health, Delaware residents will choose from two doctor-guided plans at launch. Essential (semaglutide injection): $179 first month, then $299/month. Performance (tirzepatide injection): $339 first month, then $439/month. Every plan includes physician consultation, medication, and shipping.

Are the doctors licensed in Delaware?

Every prescription will come from a physician licensed in Delaware. We work exclusively with US-licensed physicians who hold active credentials with the Delaware Board of Medical Licensure and Discipline.

How fast can I get started in Delaware?

The process is designed so that the assessment, physician review, and pharmacy shipping fit within about 5 to 7 business days once we open. Shipping is planned to reach every Delaware address, including Wilmington and Dover.

Is GLP-1 telehealth legal in Delaware?

Delaware allows licensed physicians to prescribe non-controlled medications via telehealth, including compounded GLP-1 medications dispensed by state-licensed pharmacies.

Sources

The regulatory and population figures on this page come from the following. Links open the original.

  1. 1.Delaware Board of Medical Licensure and Discipline · State of Delaware
  2. 2.24 Del. C. Chapter 60, Provisions Applicable to Telehealth and Telemedicine (sections 6001-6005) · Delaware General Assembly, Delaware Code Online
  3. 3.Delaware Medicaid: GLP-1 coverage for weight management · Delaware Health and Social Services, Division of Medicaid and Medical Assistance (Delaware Medical Assistance Portal Document Repository), 2026 Delaware Medicaid Preferred Drug List (PDL)
  4. 4.Delaware pharmacy license lookup · Delaware Division of Professional Regulation, DELPROS online licensing portal (linked from the Board of Pharmacy page https://dpr.delaware.gov/boards/pharmacy/ as "Verify License Online")
  5. 5.24 Del. C. section 6004(a) (Practice requirements), read with section 6003(b) and (c) · Official source
  6. 6.Adult Overweight and Obesity · National Institute of Diabetes and Digestive and Kidney Diseases
  7. 7.American Community Survey and Census data tables · U.S. Census Bureau
By state

GLP-1 telehealth near Delaware

Treatment is governed by the state you are physically in when you have your visit, not the state you travel to. If you split your time, read the page for each one.

All 50 states

Join early access in Delaware

We will email you when enrollment opens in Delaware.

Start Your Assessment